Clindamycin Phosphate
- Product NDC
- 73473-302
- 11-digit product format
- 734730302
- Labeler code
- 73473
- Product ID
- 73473-302_3a42199c-8c43-4fe7-83fc-4dd5af82279d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- clindamycin phosphate
- Dosage form
- GEL
- Route
- TOPICAL
- Labeler
- Solaris Pharma Corporation
- Application
- ANDA212842
- Marketing category
- ANDA
- Marketing start
- 2024-09-15
- Substance
- CLINDAMYCIN PHOSPHATE
- Active strength
- 1 g/10mL
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Clindamycin Phosphate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CLINDAMYCIN PHOSPHATE | 1 g/10mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | EH6D7113I8 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 73473-302-75 | Clindamycin Phosphate | 75 mL in 1 BOTTLE | GEL | 75 | | 5 |
| 73473-302-75 | Clindamycin Phosphate | 1 in 1 CARTON | GEL | 1 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 73473-302 | CLINDAMYCIN PHOSPHATE GEL [SOLARIS PHARMA CORPORATION] | 5 | Current NDC, Legacy NDC, 2 package rows | 20240918_fde07866-b012-47ad-932e-b76f141f86ee.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 73473-302-75 | 73473030275 | 1 BOTTLE in 1 CARTON (73473-302-75) / 75 mL in 1 BOTTLE | 1 bottle | 2024-09-15 | 0000-00-00 | No | No | Current |